<DOC>
	<DOCNO>NCT02489344</DOCNO>
	<brief_summary>Primary Objective : To assess long-term safety GZ/SAR402671 adult male patient Fabry disease previously complete study ACT13739 . Secondary Objective : To assess long-term effect GZ/SAR402671 pharmacodynamic exploratory efficacy endpoint adult male patient Fabry disease previously complete study ACT13739 .</brief_summary>
	<brief_title>Evaluation Long-term Safety , Pharmacodynamics , Exploratory Efficacy GZ/SAR402671 Treatment-Na√Øve Adult Male Patients With Fabry Disease</brief_title>
	<detailed_description>The total duration study period 31 month .</detailed_description>
	<mesh_term>Fabry Disease</mesh_term>
	<criteria>Inclusion criterion : Male patient Fabry disease previously complete study ACT13739 . Patients , willing able provide sign informed consent . Sexually active patient , willing practice true abstinence line prefer usual lifestyle use two acceptable effective method contraception . Exclusion criterion : Patients , opinion Investigator , unable adhere requirement study . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>